Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series

References

• CDC. Guidelines for Vaccinating Kidney Dialysis Patients and Patients with Chronic Kidney Disease, summarized from Recommendations of the Advisory Committee on Immunization Practices (ACIP). December 2012
   Google Scholar
• Filippelli M, Lionetti E, Gennaro A, et al. Hepatitis B vaccine by intradermal route in non responder patients: An update. World J Gastroenterol. 2014;20(30):10383–10394
   PubMed Web of Science ®Google Scholar
• Snydman DR, Bryan JA, London WT, et al. Transmission of hepatitis B associated with hemodialysis: Role of malfunction (blood leaks) in dialysis machines. J Infect Dis. 1976;134(6):562–570
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Dixit V, Messa P, Martin P. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: A meta-analysis of randomized trials. J Viral Hepat. 2011;18(10):730–737
   PubMed Web of Science ®Google Scholar
• Hyams KC. Risks of chronicity following acute hepatitis B virus infection: A review. Clin Infect Dis. 1995;20(4):992–1000. [Review]
   PubMed Web of Science ®Google Scholar
• Lin SY, Liu JH, Wang SM, et al. Association of response to hepatitis B vaccination and survival in dialysis patients. BMC Nephrol. 2012;13:97
   PubMed Web of Science ®Google Scholar
• Sirsat RA, Shah BV, Nair S, Shetty D, Rodriguest C, Mehta A. Efficacy of low dose intradermal recombinant hepatitis B vaccine with and without immunomodulation in end stage renal disease patients on maintenance hemodialysis. J Assoc Physicians India. 1995;43(3):191–192
   PubMedGoogle Scholar
• Vlassopoulos D, Arvanitis D, Lilis D, Hatjiyannakos D, Louizou K, Hadjiconstantinou V. Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients. Ren Fail. 1997;19(3):455–460
   PubMed Web of Science ®Google Scholar
• Radziszewski A, Gajda M, Pituch-Noworolska A, et al. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization. Przegl Lek. 2007;64(7–8):470–475
   PubMedGoogle Scholar
• Barraclough KA, Wiggins KJ, Hawley CM, et al. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: A prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis. 2009;54(1):95–103. Erratum in: Am J Kidney Dis. 2009;54(2):393. Dosage error in published abstract; MEDLINE/PubMed abstract corrected
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Andrulli S, Bacchini G, Corti M, Locatelli F. Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients: A prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant. 1997;12(6):1204–1211
   PubMed Web of Science ®Google Scholar
• Sticchi L, Alberti M, Alicino C, Crovari P. The intradermal vaccination: Past experiences and current perspectives. J Prev Med Hyg. 2010;51(1):7–14
   PubMedGoogle Scholar
• Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408–412
   PubMed Web of Science ®Google Scholar
• Micozkadioglu H, Zumrutdal A, Torun D, Sezer S, Ozdemir FN, Haberal M. Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. Ren Fail. 2007;29(3):285–288
   PubMed Web of Science ®Google Scholar
• Mast EE, Weinbaum CM, Fiore AE, et al., Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults. MMWR Recomm Rep. 2006;55(RR-16):1–33; quiz CE1--4. Erratum in: MMWR Morb Mortal Wkly Rep. 2007;56(42):1114
   PubMedGoogle Scholar
• Chang PC, Schrander-van der Meer AM, van Dorp WT, van Leer E. Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients. Nephrol Dial Transplant. 1996;11(1):191–193
   PubMed Web of Science ®Google Scholar
• Sorkhi H, Dooki MR, Ebrahimnejad MS. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients. J Med Assoc Thai. 2006;89(10):1648–1653
   PubMedGoogle Scholar
• Kim YC, Prausnitz MR. Enabling skin vaccination using new delivery technologies. Drug Deliv Transl Res. 2011;1(1):7–12
   PubMed Web of Science ®Google Scholar
• Bryan JP, Sjogren MH, Perine PL, Legters LJ. Low-dose intradermal and intramuscular vaccination against hepatitis B. Clin Infect Dis. 1992;14(3):697–707
   PubMed Web of Science ®Google Scholar
• McFaul SJ, Bowman PD, Villa VM. Hemoglobin stimulates the release of proinflammatory cytokines from leukocytes in whole blood. J Lab Clin Med. 2000;135(3):263–269
   PubMedGoogle Scholar
• Hashemi B, Mahdavi-Mazdeh M, Abbasi M, et al. Efficacy of HBV vaccination in various stages of chronic kidney disease: Is earlier better? Hepat Mon. 2011;11(10):816–820
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V, Stefanidis I. Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients. World J Gastroenterol. 2014;20(34):12018–12025
   PubMed Web of Science ®Google Scholar
• Yorioka N, Hamaguchi N, Takasugi N, et al. Effect of recombinant human erythropoietin administration on immunological indices in patients undergoing chronic hemodialysis. Nihon Jinzo Gakkai Shi. 1993;35(8):981–988
   PubMedGoogle Scholar
• Bruguera M, Rodicio JL, Alcazar JM, Oliver A, Del Rio G, Esteban-Mur R. Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in hemodialysis patients. Vaccine. 1990;8(Suppl.):S47–S49; discussion S60–S62
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Dixit V, Magnini M, Elli A, Martin P. Meta-analysis: Intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment Pharmacol Ther. 2006;24(3):497–506
   PubMed Web of Science ®Google Scholar
• Bommer J, Ritz E, Andrassy K, et al. Effect of vaccination schedule and dialysis on hepatitis B vaccination response in uraemic patients. Proc Eur Dial Transplant Assoc. 1983;20:161–168
   PubMedGoogle Scholar